Solvay Pharma India Ltd.

factsheet Factsheet
  • Value Research Rating market-capitalisation-info
    UnratedSee Why?
  • Market Capitalisation market-capitalisation-info ₹1,081 Cr
  • price-to-earning --
  • 12 Month Earnings monthly-earning ₹51 Cr

Solvay Pharma India Ltd. Share Price

As on

  • Prev Close info

  • Day's Openinfo

  • Today's Highinfo

  • Today's Lowinfo

  • Today's Volumeinfo

  • 52 Week rangeinfo

    ₹-- - --

Please wait...

Solvay Pharma India Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
S&P BSE Sensex
0.09 2.27 9.60 21.95 13.77 15.03 13.17
S&P BSE Healthcare
11.95 7.10 18.77 61.97 19.20 20.83 12.79
#
-- -- -- -- -- -- --
As on 28-Feb-2024  |  #As on
The underlying data is unavailable.

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Solvay Pharma India Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Solvay Pharma India Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Solvay Pharma India Ltd.

        No Review & Analysis are available.

        Other details of Solvay Pharma India Ltd.

        Incorporated

        1999

        Chairman

        Roland Kaut

        Managing Director

        Niteen B Gadgil

        Group

        Solvay Pharma - MNC

        Headquarters

        Mumbai, Maharashtra

        FAQs for Solvay Pharma India Ltd.

        The total asset value of Solvay Pharma India Ltd. stood at ₹ 220 Cr as on 31-Dec-10

        Solvay Pharma India Ltd. has a market capitalisation of ₹ 1,081 Cr as on 25-Aug-2011. As per Value Research classification, it is a company.

        The P/B ratio of Solvay Pharma India Ltd. is 6.11 times as on 25-Aug-2011, a 0.46% premium to its peers’ median range of 4.18 times.

        The P/E ratio of Solvay Pharma India Ltd. is 21.30 times as on 25-Aug-2011, a -0.51% premium to its peers’ median range of 43.89 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Solvay Pharma India Ltd. and enter the required number of quantities and click on buy to purchase the shares of Solvay Pharma India Ltd..

        Manufacture of allopathic pharmaceutical preparations

        There is no prominent promoters in Solvay Pharma India Ltd..

        The promoters of Solvay Pharma India Ltd. have pledged 0% of the total equity as on Jun-11.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        Solvay Pharma India Ltd. Ratios
        Return on equity(%)
        --
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        --
        Dividend yield(%)
        --

        Yes, TTM profit after tax of Solvay Pharma India Ltd. was ₹51 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Review & Analysis

        No Review & Analysis are available.

        News & Announcements

        No News & Announcements are available.

        Key Facts

        • Market cap market-cap-information ₹1,081.42 Cr
        • Revenue (TTM)revenue-information 294.73 Cr
        • Earnings (TTM) earning-information 50.85 Cr
        • Cash date-information 87.81 Cr
        • Total Debt info 0.00 Cr
        • Promoters' ownership promoters_ownership 88.85%
        • Liquidity liquidity
        • 52 Week range week-range ₹-- - --
        • Face value face-value 10.00
        • Shares outstanding share-outstanding 50,49,706
        • 10 Years Aggregate:

          CFO: 195.53 Cr

          EBITDA: 365.62 Cr

          Net Profit: 242.69 Cr

        About The Company

        • Incorporated 1999
        • Chairman Roland Kaut
        • Managing Director Niteen B Gadgil
        • Group Solvay Pharma - MNC
        • Listing key-listing BSE: 532447
        • Country India
        • Headquarters headquarters Mumbai, Maharashtra
        • Website website www.solvaypharma.co.in
        • Business

          Manufacture of allopathic pharmaceutical preparations